“Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Potential CYP51B Inhibitors Against Aspergillus fumigatus” (2026) Al Mustansiriyah Journal of Pharmaceutical Sciences, 26(3), pp. 302–315. doi:10.32947/ajps.v26i3.1420.